Matthew Balk - Net Worth and Insider Trading

Matthew Balk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Balk owns 2 companies in total, including Entero Therapeutics Inc (ENTO) , and Quantrx Biomedical Corp (QTXB) .

Click here to see the complete history of Matthew Balk’s form 4 insider trades.

Insider Ownership Summary of Matthew Balk

Ticker Comapny Transaction Date Type of Owner
ENTO Entero Therapeutics Inc 2016-10-11 10 percent owner
QTXB Quantrx Biomedical Corp 2007-03-09 10 percent owner

Matthew Balk Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Balk Ownership Network

Ownership Network List of Matthew Balk

No Data

Ownership Network Relation of Matthew Balk

Insider Network Chart

Matthew Balk Owned Company Details

What does Entero Therapeutics Inc do?

Who are the key executives at Entero Therapeutics Inc?

Matthew Balk is the 10 percent owner of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include Chief Financial Officer Sarah Romano , director & President and CEO James Sapirstein , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .

Entero Therapeutics Inc (ENTO) Insider Trades Summary

Over the past 18 months, Matthew Balk made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 3,117 shares made by Sarah Romano , and a net sale of 3,516 shares made by James Sapirstein .

In summary, during the past 3 months, insiders sold 0 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,633 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,633 shares.

Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entero Therapeutics Inc Insider Transactions

No Available Data

Matthew Balk Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Balk. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Balk's mailing address is: New York Ny 10023.